Medigene AG (MDGEF)
OTCMKTS · Delayed Price · Currency is USD
2.590
0.00 (0.00%)
Apr 30, 2025, 4:00 PM EDT

Medigene AG Statistics

Total Valuation

Medigene AG has a market cap or net worth of 2.24 million. The enterprise value is -10.84 million.

Market Cap 2.24M
Enterprise Value -10.84M

Important Dates

The next estimated earnings date is Friday, August 15, 2025.

Earnings Date Aug 15, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +2.65%
Shares Change (QoQ) +5.09%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 14.24M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.28
PB Ratio 0.11
P/TBV Ratio 0.21
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 0.64
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 0.68

Financial Position

The company has a current ratio of 2.39, with a Debt / Equity ratio of 0.13.

Current Ratio 2.39
Quick Ratio 2.22
Debt / Equity 0.13
Debt / EBITDA n/a
Debt / FCF -0.17
Interest Coverage -28.34

Financial Efficiency

Return on equity (ROE) is -63.93% and return on invested capital (ROIC) is -34.49%.

Return on Equity (ROE) -63.93%
Return on Assets (ROA) -27.15%
Return on Invested Capital (ROIC) -34.49%
Return on Capital Employed (ROCE) -69.20%
Revenue Per Employee 91,703
Profits Per Employee -196,226
Employee Count 76
Asset Turnover 0.21
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +6.58% in the last 52 weeks. The beta is 0.91, so Medigene AG's price volatility has been similar to the market average.

Beta (5Y) 0.91
52-Week Price Change +6.58%
50-Day Moving Average 2.23
200-Day Moving Average 1.63
Relative Strength Index (RSI) 100.00
Average Volume (20 Days) n/a

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Medigene AG had revenue of 7.98 million and -17.07 million in losses. Loss per share was -1.35.

Revenue 7.98M
Gross Profit 6.38M
Operating Income -16.52M
Pretax Income -16.74M
Net Income -17.07M
EBITDA -15.84M
EBIT -16.52M
Loss Per Share -1.35
Full Income Statement

Balance Sheet

The company has 15.03 million in cash and 2.73 million in debt, giving a net cash position of 12.30 million.

Cash & Cash Equivalents 15.03M
Total Debt 2.73M
Net Cash 12.30M
Net Cash Per Share n/a
Equity (Book Value) 21.07M
Book Value Per Share 1.43
Working Capital 9.75M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -15.19 million and capital expenditures -665,381, giving a free cash flow of -15.85 million.

Operating Cash Flow -15.19M
Capital Expenditures -665,381
Free Cash Flow -15.85M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 79.94%, with operating and profit margins of -207.04% and -213.98%.

Gross Margin 79.94%
Operating Margin -207.04%
Pretax Margin -209.76%
Profit Margin -213.98%
EBITDA Margin -198.51%
EBIT Margin -207.04%
FCF Margin n/a

Dividends & Yields

Medigene AG does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2.65%
Shareholder Yield -2.65%
Earnings Yield -761.14%
FCF Yield -706.73%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Medigene AG has an Altman Z-Score of -22.4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -22.4
Piotroski F-Score n/a